Searched for
REVATIO
Sensex slips over 100 points, Nifty below 7,850; SpiceJet up 3%, Adani Ports 2%The S&P BSE Sensex started on a cautious note in morning trade on Monday, led by gains in Bajaj Auto, ICICI Bank, HDFC Bank, RIL, and Dr Re...- Lupin rallies 4% after multiple approvals from USFDAIn a regulatory filing, the company said it has received approval from the USFDA for mirabegron extended-release tablets.
- Market movers: Why did Lupin jump 4% & OMCs take a big hit due to electionsPharma stocks have been in demand given the rapid rise in dollar, which boosts the prospects of the export oriented companies. And, at such...
- Fifteen stocks in focus in Monday morning tradeThe Indian market is expected to trade higher. Here is a list of top fifteen stocks that are likely to be in focus today.
- Aurobindo Pharma gets USFDA nod for generic of Pfizer's RevatioAurobindo Pharma received approval from the USFDA to manufacture and market generic version of Pfizer's Revatio tablets used in the treatme...
- Aurobindo Pharma shares gain 6.5 per cent on USFDA nodThe scrip jumped 6.19 per cent to settle the day at Rs 1,324.95 on the BSE. In intra-day, it gained 6.59 per cent to Rs 1,330, its 52-week ...
- Aurobindo Pharma gets USFDA nod for Sildenafil injectionUSFDA-approved Sildenafil injection, treats pulmonary arterial hypertension and is a generic version of Pfizer's Revatio injection.
- Brokers' call: ITC, Infosys, pharmaITC’s cigarette business has delivered consistent high teens profit growth over the past six years, despite rising taxes.
- Lupin to gain from Tricor launch in US, says NomuraNomura analysts said that Lupin's launch of generic Tricor in the US is positive for the company and could emerge with the largest market s...
- Dr Reddy's announces launch of Sildenafil tabletsThis followed the approval by the United States Food & Drug Administration of Dr Reddy's ANDA for Sildenafil tablets, a company statement s...
Load More
